Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (131-140 of 319) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapyMatthew R Smith, Judith Manola, Donald S Kaufman, et al.
Cancer|October 31, 2002
Selective aromatase inhibition for patients with androgen-independent prostate carcinomaMatthew R Smith, Donald Kaufman, Daniel George, et al.
Clinical Lymphoma & Myeloma|June 15, 2007
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myelomaAllan Lipton, Richard J Cook, Robert E Coleman, et al.
Expert Opinion on Investigational Drugs|March 1, 2006
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapySamir S Taneja, Matthew R Smith, James T Dalton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsAllan Lipton, Robert Uzzo, Robert J Amato, et al.
CA: a Cancer Journal for Clinicians|May 27, 2008
Management of complications of prostate cancer treatmentM Dror Michaelson, Shane E Cotter, Patricio C Gargollo, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 15, 2026
Operating Room Extubation After Cardiac Surgery: A Promising Practice, or a Product of Selection Bias?Chelsea J Messinger, Elizabeth Hall, Matthew R Smith, et al.
The Journal of Urology|June 18, 2011
Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Ronald A Morton, Michael L Hancock, et al.
The Journal of Urology|October 22, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerMatthew R Smith, S Bruce Malkowicz, Michael K Brawer, et al.
Cancer|March 19, 2008
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndromeMatthew R Smith, Hang Lee, Francis McGovern, et al.
Pageof 32

Showing results (131-140 of 319) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapyMatthew R Smith, Judith Manola, Donald S Kaufman, et al.
Cancer|October 31, 2002
Selective aromatase inhibition for patients with androgen-independent prostate carcinomaMatthew R Smith, Donald Kaufman, Daniel George, et al.
Clinical Lymphoma & Myeloma|June 15, 2007
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myelomaAllan Lipton, Richard J Cook, Robert E Coleman, et al.
Expert Opinion on Investigational Drugs|March 1, 2006
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapySamir S Taneja, Matthew R Smith, James T Dalton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsAllan Lipton, Robert Uzzo, Robert J Amato, et al.
CA: a Cancer Journal for Clinicians|May 27, 2008
Management of complications of prostate cancer treatmentM Dror Michaelson, Shane E Cotter, Patricio C Gargollo, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 15, 2026
Operating Room Extubation After Cardiac Surgery: A Promising Practice, or a Product of Selection Bias?Chelsea J Messinger, Elizabeth Hall, Matthew R Smith, et al.
The Journal of Urology|June 18, 2011
Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Ronald A Morton, Michael L Hancock, et al.
The Journal of Urology|October 22, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerMatthew R Smith, S Bruce Malkowicz, Michael K Brawer, et al.
Cancer|March 19, 2008
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndromeMatthew R Smith, Hang Lee, Francis McGovern, et al.
Pageof 32